{
    "Trade/Device Name(s)": [
        "BD Phoenix Automated Microbiology System Cefoxitin (1-32 \u00b5g/mL)",
        "BD PhoenixM Automated Microbiology System for use with the antimicrobial agent cefoxitin (1-32 \u00b5g/mL) - Gram positive ID/AST or AST only Phoenix panels"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K053241",
    "Predicate Device Reference 510(k) Number(s)": [
        "N50510",
        "K020321",
        "K020322",
        "K020323"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "December 22, 2005",
    "Summary Letter Received Date": "November 18, 2005",
    "Submission Date": "November 16, 2005",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility Devices"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Cefoxitin"
    ],
    "Specimen Type(s)": [
        "Pure culture isolates",
        "Gram-positive bacteria",
        "Gram-negative bacteria"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Automated broth microdilution",
        "Redox indicator detection"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing (AST)",
        "Minimum inhibitory concentration (MIC) determination"
    ],
    "Submission Type(s)": [
        "Automated system",
        "Panel",
        "Reagent",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix Automated Microbiology System cefoxitin (1-32 \u00b5g/mL) panels for antimicrobial susceptibility testing of Gram-positive bacteria.",
    "Indications for Use Summary": "Intended for in vitro quantitative determination of antimicrobial susceptibility by MIC for most Gram-negative aerobic and facultative anaerobic bacteria isolates and most Gram-positive bacteria isolates (Staphylococcus and Enterococcus) from pure culture; includes cefoxitin (1-32 \u00b5g/mL) for Gram Positive ID/AST or AST only Phoenix panels, and prediction of mecA-mediated resistant Staphylococcus aureus.",
    "fda_folder": "Microbiology"
}